Stay updated on Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedSite update adds Revision: v3.4.2 and removes the prior funding notice and Revision: v3.4.1.SummaryDifference0.5%

- Check22 days agoChange DetectedA government funding notice banner was added and the page revision tag updated to v3.4.1, while the previous revision tag v3.4.0 was removed.SummaryDifference0.5%

- Check29 days agoChange DetectedAdded a glossary toggle and updated QC-related labels to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', with the revision indicator updated to v3.4.0. The older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page's revision history shows an addition of Revision: v3.3.4 and a deletion of Revision: v3.3.3. This reflects metadata updates rather than changes to the study data.SummaryDifference0.1%

- Check65 days agoChange DetectedA new Locations section including North Holland was added, and the HHS Vulnerability Disclosure and North Holland Locations entries were removed; the page revision updated to v3.3.3.SummaryDifference0.2%

- Check86 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2. No changes to the study details or substantive content.SummaryDifference0.1%

Stay in the know with updates to Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page.